oxotremorine has been researched along with Leukemia, T-Cell in 1 studies
Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.
Leukemia, T-Cell: A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaneda, T | 1 |
| Kitamura, Y | 1 |
| Nomura, Y | 1 |
1 other study available for oxotremorine and Leukemia, T-Cell
| Article | Year |
|---|---|
Presence of m3 subtype muscarinic acetylcholine receptors and receptor-mediated increases in the cytoplasmic concentration of Ca2+ in Jurkat, a human leukemic helper T lymphocyte line.
Topics: Blotting, Northern; Calcium; GTP-Binding Proteins; Humans; Leukemia, T-Cell; Oxotremorine; Parasympa | 1993 |